AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Carcinoma of the pancreas: Special issue editor
Authors: Abbruzzese, JL
Citation: Jl. Abbruzzese, Carcinoma of the pancreas: Special issue editor, CANCER J, 7(4), 2001, pp. 241-241
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma
Authors: Wolff, RA Evans, DB Gravel, DM Lenzi, R Pisters, PWT Lee, JE Janjan, NA Charnsangavej, C Abbruzzese, JL
Citation: Ra. Wolff et al., Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma, CLIN CANC R, 7(8), 2001, pp. 2246-2253
In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody1F7 on human CD30+anaplastic large cell T-cell lymphoma Karpas 299
Authors: Ho, L Aytac, U Stephens, LC Ohnuma, K Mills, GB McKee, KS Neumann, C LaPushin, R Cabanillas, F Abbruzzese, JL Morimoto, C Dang, NH
Citation: L. Ho et al., In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody1F7 on human CD30+anaplastic large cell T-cell lymphoma Karpas 299, CLIN CANC R, 7(7), 2001, pp. 2031-2040
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration
Authors: Breslin, TM Hess, KR Harbison, DB Jean, ME Cleary, KR Dackiw, AP Wolff, RA Abbruzzese, JL Janjan, NA Crane, CIH Vauthey, JN Lee, JE Pisters, PWT Evans, DB
Citation: Tm. Breslin et al., Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration, ANN SURG O, 8(2), 2001, pp. 123-132
Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma
Authors: Kuniyasu, H Abbruzzese, JL Cleary, KR Fidler, IJ
Citation: H. Kuniyasu et al., Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma, INT J ONCOL, 19(4), 2001, pp. 681-685
Regulation of vascular endothelial growth factor expression by acidosis inhuman cancer cells
Authors: Shi, Q Le, XD Wang, BL Abbruzzese, JL Xiong, QH He, YJ Xie, KP
Citation: Q. Shi et al., Regulation of vascular endothelial growth factor expression by acidosis inhuman cancer cells, ONCOGENE, 20(28), 2001, pp. 3751-3756
Matrix metalloproteinase inhibition of pancreatic cancer: Matching mechanism of action to clinical trial design
Authors: Hess, KR Abbruzzese, JL
Citation: Kr. Hess et Jl. Abbruzzese, Matrix metalloproteinase inhibition of pancreatic cancer: Matching mechanism of action to clinical trial design, J CL ONCOL, 19(15), 2001, pp. 3445-3446
T4 rectal cancer treated with preoperative chemoradiation to the posteriorpelvis followed by multivisceral resection: Patterns of failure and limitations of treatment
Authors: Sanfilippo, NJ Crane, CH Skibber, J Feig, B Abbruzzese, JL Curley, S Vauthey, JN Ellis, LM Hoff, P Wolff, RA Brown, TD Cleary, K Wong, A Phan, T Janjan, NA
Citation: Nj. Sanfilippo et al., T4 rectal cancer treated with preoperative chemoradiation to the posteriorpelvis followed by multivisceral resection: Patterns of failure and limitations of treatment, INT J RAD O, 51(1), 2001, pp. 176-183
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer
Authors: Crane, CH Janjan, NA Abbruzzese, JL Curley, S Vauthey, JN Sawaf, HB Dubrow, R Allen, P Ellis, LM Hoff, P Wolff, RA Lenzi, R Brown, TD Lynch, P Cleary, K Rich, TA Skibber, J
Citation: Ch. Crane et al., Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer, INT J RAD O, 49(1), 2001, pp. 107-116
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
Authors: Crane, CH Janjan, NA Evans, DB Wolff, RA Ballo, MT Milas, L Mason, K Charnsangavej, C Pisters, PWT Lee, JE Lenzi, R Vauthey, JN Wong, A Phan, T Nguyen, Q Abbruzzese, JL
Citation: Ch. Crane et al., Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer, INT J PANCR, 29(1), 2001, pp. 9-18
Mouse models of metastatic pancreatic adenocarcinoma
Authors: Xie, KP Wang, BL Shi, Q Abbruzzese, JL Xiong, QH Le, XD
Citation: Kp. Xie et al., Mouse models of metastatic pancreatic adenocarcinoma, INT J PANCR, 29(1), 2001, pp. 25-35
A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy
Authors: Wang, BL Shi, Q Abbruzzese, JL Xiong, Q Le, XD Xie, KP
Citation: Bl. Wang et al., A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma biology and therapy, INT J PANCR, 29(1), 2001, pp. 37-46
Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic index
Authors: Crane, CH Wolff, RA Abbruzzese, JL Evans, DB Milas, L Mason, K Charnsangavej, C Pisters, PWT Lee, JE Lenzi, R Lahoti, S Vauthey, JN Janjan, NA
Citation: Ch. Crane et al., Combining gemcitabine with radiation in pancreatic cancer: Understanding important variables influencing the therapeutic index, SEMIN ONCOL, 28(3), 2001, pp. 25-33
Tumor suppressor MMAC/PTEN inhibits cytokine-induced NF kappa B activationwithout interfering with the I kappa B degradation pathway
Authors: Koul, D Yao, YX Abbruzzese, JL Yung, WKA Reddy, SAG
Citation: D. Koul et al., Tumor suppressor MMAC/PTEN inhibits cytokine-induced NF kappa B activationwithout interfering with the I kappa B degradation pathway, J BIOL CHEM, 276(14), 2001, pp. 11402-11408
Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma
Authors: Shi, Q Le, XD Abbruzzese, JL Peng, ZH Qian, CN Tang, HM Xiong, QH Wang, BL Li, XC Xie, KP
Citation: Q. Shi et al., Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma, CANCER RES, 61(10), 2001, pp. 4143-4154
Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma
Authors: Wang, BL Xiong, QH Shi, Q Le, XD Abbruzzese, JL Xie, KP
Citation: Bl. Wang et al., Intact nitric oxide synthase II gene is required for interferon-beta-mediated suppression of growth and metastasis of pancreatic adenocarcinoma, CANCER RES, 61(1), 2001, pp. 71-75
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck
Authors: Tseng, JE Glisson, BS Khuri, FR Shin, DM Myers, JN El-Naggar, AK Roach, JS Ginsberg, LE Thall, PF Wang, XM Teddy, S Lawhorn, KN Zentgraf, RE Steinhaus, GD Pluda, JM Abbruzzese, JL Hong, WK Herbst, RS
Citation: Je. Tseng et al., Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck, CANCER, 92(9), 2001, pp. 2364-2373
Molecular diagnosis of pancreatic and biliary cancer: Ready for broad implementation?
Authors: Abbruzzese, JL
Citation: Jl. Abbruzzese, Molecular diagnosis of pancreatic and biliary cancer: Ready for broad implementation?, CANCER J, 6(5), 2000, pp. 282-284
Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma
Authors: Le, XD Shi, Q Wang, BL Xiong, QH Qian, CN Peng, ZH Li, XC Tang, HM Abbruzzese, JL Xie, KP
Citation: Xd. Le et al., Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma, J INTERF CY, 20(11), 2000, pp. 935-946
Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells
Authors: Shi, Q Le, XD Wang, BL Xiong, QH Abbruzzese, JL Xie, KP
Citation: Q. Shi et al., Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells, J INTERF CY, 20(11), 2000, pp. 1023-1028
Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms
Authors: Bruns, CJ Harbison, MT Davis, DW Portera, CA Tsan, R McConkey, DJ Evans, DB Abbruzzese, JL Hicklin, DJ Radinsky, R
Citation: Cj. Bruns et al., Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms, CLIN CANC R, 6(5), 2000, pp. 1936-1948
Novel marine-derived anticancer agents: A phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients withadvanced solid tumors
Authors: Madden, T Tran, HT Beck, D Huie, R Newman, RA Pusztai, L Wright, JJ Abbruzzese, JL
Citation: T. Madden et al., Novel marine-derived anticancer agents: A phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients withadvanced solid tumors, CLIN CANC R, 6(4), 2000, pp. 1293-1301
The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration
Authors: Pearson, AS Chiao, P Zhang, L Zhang, W Larry, L Katz, RL Evans, DB Abbruzzese, JL
Citation: As. Pearson et al., The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration, INT J ONCOL, 17(2), 2000, pp. 381-385
Preoperative chemoradiation for patients with pancreatic cancer: Toxicity of endobiliary stents
Authors: Pisters, PWT Hudec, WA Lee, JE Raijman, I Lahoti, S Janjan, NA Rich, TA Crane, CH Lenzi, R Wolff, RA Abbruzzese, JL Evans, DB
Citation: Pwt. Pisters et al., Preoperative chemoradiation for patients with pancreatic cancer: Toxicity of endobiliary stents, J CL ONCOL, 18(4), 2000, pp. 860-867
Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer
Authors: Hoff, PM Janjan, N Saad, ED Skibber, J Crane, C Lassere, Y Cleary, KR Benner, S Randolph, J Abbruzzese, JL Pazdur, R
Citation: Pm. Hoff et al., Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer, J CL ONCOL, 18(20), 2000, pp. 3529-3534
Risultati: 1-25 | 26-43